Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Dual viscoelastic choices make product a favorite for cataract surgery in difficult situations
DuoVisc (Alcon Laboratories, Fort Worth, TX)-packaging the cohesive ProVisc (1% sodium hyaluronate) and the dispersive Viscoat (3% sodium hyaluronate/4% chondroitin sulfate) together in a single unit-is an excellent viscoelastic choice for almost all cataract surgery cases and for surgeons across all levels of expertise, agree I. Howard Fine, MD, and Susan M. MacDonald, MD.
Related Videos
Related Content
